Cue COVID-19 Test - Minnesota Dept. of Health

Information for Organizations Requesting Cue Rapid Molecular Tests

The Cue rapid molecular test (nucleic acid amplification test), which received emergency use authorization from the Food and Drug Administration, uses a device, test cartridge, and nasal swab to deliver COVID-19 test results to an iPhone, iPad, or android device (i.e., mobile app only) in 20 minutes.

There are two types of Cue tests:

When an organization administers either type of Cue test on-site, the tests must be:

  • Administered in a facility with a Clinical Laboratory Improvement Amendments (CLIA) certificate or CLIA certificate of waiver; and
  • Performed by a trained staff member.

Resources from Cue:

To request a biweekly supply of the tests:

Demand for the Cue tests may exceed supply. If that happens, MDH will prioritize entities serving priority populations and geographic areas with high test positivity rates, where testing access is limited, and/or where the population is disproportionately at risk.

Questions? Email:

Updated Monday, 29-Nov-2021 14:52:53 CST